SNDX

Syndax Pharmaceuticals Inc

—

$22.08

-4.95% today

last filing 2026-02-09Pro sees filings in ~15 min

Price

hover · 4 moves explained

10 sells

Analyst consensus

$39.00target+76.6%vs $22.08 today

$29.00 low today target$57.00 high

12 analysts · ~12-month consensus · as of Jul 7. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25+17.5%

−$0.83

exp −$1.01

Q3 '25+1.5%

−$0.70

exp −$0.71

Q4 '25-34.9%

−$0.78

exp −$0.58

Q1 '26+18.8%

−$0.48

exp −$0.59

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-02-10	Metzger Michael A	Chief Executive Officer	—Direct	17,159	$21.03	$360.8K
Sell	2026-02-10	Goldan Keith A.	Chief Financial Officer	—Direct	3,410	$21.03	$71.7K
Sell	2026-02-06	Metzger Michael A	Chief Executive Officer	—Direct	7,412	$20.62	$152.8K
Sell	2026-02-06	Goldan Keith A.	Chief Financial Officer	—Direct	2,082	$20.62	$42.9K
Grant	2026-02-06	Rizo Aleksandra	Director	—Direct	24,000	—	—

Sell

Metzger Michael A

Chief Executive Officer · 2026-02-10

$360.8K

17,159 @ $21.03

Sell

Goldan Keith A.

Chief Financial Officer · 2026-02-10

$71.7K

3,410 @ $21.03

Sell

Metzger Michael A

Chief Executive Officer · 2026-02-06

$152.8K

7,412 @ $20.62

Sell

Goldan Keith A.

Chief Financial Officer · 2026-02-06

$42.9K

2,082 @ $20.62

Grant

Rizo Aleksandra

Director · 2026-02-06

—

24,000 shares

24 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →